The comparison of mouse full metallothionein-1 versus α and β domains and metallothionein-1-to-3 mutation following traumatic brain injury reveals different biological motifs

Journal of Neuroscience Research

Volumn 88, Issue 8, 2010, Pages 1708-1718

  Manso, Yasmina ^a   Serra, Montserrat ^b   Comes, Gemma ^a   Giralt, Mercedes ^a   Carrasco, Javier ^a   Cols, Neus ^c   Vašák, Milan ^d   González Duarte, Pilar ^b   Hidalgo, Juan ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Full MT 1; MT 1 domains; MT 1 to MT 3 mutation; Traumatic brain injury

Indexed keywords

CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; MORTALITY; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; ROTAROD TEST; SURVIVAL RATE; TRAUMATIC BRAIN INJURY; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; BRAIN INJURIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; METALLOTHIONEIN; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; NERVE TISSUE PROTEINS; PROTEIN STRUCTURE, TERTIARY; PSYCHOMOTOR PERFORMANCE;

EID: 77952357223     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22342     Document Type: Article

References (66)

1. Acarin L, González B, Hidalgo J, Castro AJ, Castellano B. 1999. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: astroglial response and metallothionein expression. Neuroscience 92:827-839. (Pubitemid 29287530)
2. Ambjørn M, Asmussen JW, Lindstam M, Gotfryd K, Jacobsen C, Kiselyov VV, Moestrup SK, Penkowa M, Bock E, Berezin V. 2008. Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low density lipoprotein receptor family. J Neurochem 104:21-37. (Pubitemid 350265072)
3. Asmussen JW, Ambjørn M, Bock E, Berezin V. 2009. Peptides modeled after the alpha-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons. Eur J Cell Biol 88:433-443.
4. Blaauwgeers HG, Sillevis Smitt PA, De Jong JM, Troost D. 1993. Distribution of metallothionein in the human central nervous system. Glia 8:62-70.
5. Capdevila M, Cols N, Romero-Isart N, Gonzalez-Duarte R, Atrian S, Gonzalez-Duarte P. 1997. Recombinant synthesis of mouse Zn3-beta and Zn4-alpha metallothionein 1 domains and characterization of their cadmium(II) binding capacity. Cell Mol Life Sci 53:681-688. (Pubitemid 27458286)
6. Carrasco J, Hernández J, González B, Campbell IL, Hidalgo J. 1998. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin 6. Exp Neurol 153:184-194. (Pubitemid 28489885)
7. Carrasco J, Penkowa M, Hadberg H, Molinero A, Hidalgo J. 2000. Enhanced seizures and hippocampal neurodegeneration following kainic acid induced seizures in metallothionein-I + II deficient mice. Eur J Neurosci 12:2311-2322. (Pubitemid 30497029)
8. Cols N, Romero-Isart N, Capdevila M, Oliva B, Gonzalez-Duarte P, Gonzalez-Duarte R, Atrian S. 1997. Binding of excess cadmium(II) to Cd7-metallothionein from recombinant mouse Zn7-metallothionein 1. UV-VIS absorption and circular dichroism studies and theoretical location approach by surface accessibility analysis. J Inorg Biochem 68:157-166. (Pubitemid 27459384)
9. Coyle J, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695. (Pubitemid 23350687)
10. Cui Y, Wang J, Zhang X, Lang R, Bi M, Guo L, Lu SH. 2003. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochem Biophys Res Commun 302:904-915. (Pubitemid 36294062)
11. Cunningham LA, Wetzel M, Rosenberg GA. 2005. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50:329-339. (Pubitemid 40780839)
12. Chiang C-S, Stalder A, Samimi A, Campbell IL. 1994. Reactive gliosis as a consequence of interleukin 6 expression in the brain: studies in transgenic mice. Dev Neurosci 16:212-221.
13. Chung RS, Vickers JC, Chuah MI, West AK. 2003. Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury. J Neurosci 23:3336-3342.
14. Chung RS, West AK. 2004. A role for extracellular metallothioneins in CNS injury and repair. Neuroscience 123:595-599. (Pubitemid 38045398)
15. Chung RS, Hidalgo J, West A. 2008a. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J Neurochem 104:14-20. (Pubitemid 350265070)
16. Chung RS, Penkowa M, Dittmann J, King CE, Bartlett C, Asmussen JW, Hidalgo J, Carrasco J, Leung YK, Walker AK, Fung SJ, Dunlop SA, Fitzgerald M, Beazley LD, Chuah MI, Vickers JC, West AK. 2008b. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyteneuron response to injury. J Biol Chem 283:15349-15358.
17. Feng W, Cai J, Pierce WM, Franklin RB, Maret W, Benz FW, Kang YJ. 2005. Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem Biophys Res Commun 332:853-858. (Pubitemid 40745191)
18. Giralt M, Penkowa M, Hernández J, Molinero A, Carrasco J, Lago N, Camats J, Campbell IL, Hidalgo J. 2002a. Metallothionein-1 + 2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Neurobiol Dis 9:319-338. (Pubitemid 34442080)
19. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J. 2002b. Metallothionein-1 + 2 protect the CNS after a focal brain injury. Exp Neurol 173:114-128. (Pubitemid 34081731)
20. Glanville N, Durnam DM, Palmiter RD. 1981. Structure of mouse metallothionein-I gene and its mRNA. Nature 292:267-269. (Pubitemid 11001850)
21. Gonçalves I, Quintela T, Baltazar G, Almeida MR, Saraiva MJ, Santos CR. 2008. Transthyretin interacts with metallothionein 2. Biochemistry 47:2244-2251.
22. Hao Q, Hong SH, Maret W. 2007. Lipid raft-dependent endocytosis of metallothionein in HepG2 cells. J Cell Physiol 210:428-435. (Pubitemid 44956888)
23. Hidalgo J, Aschner M, Zatta P, Vašák M. 2001. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55:133-145. (Pubitemid 32722153)
24. Holloway AF, Stennard FA, Dziegielewska KM, Weller L, West AK. 1997. Localisation and expression of metallothionein immunoreactivity in the developing sheep brain. Int J Dev Neurosci 15:195-203. (Pubitemid 27212075)
25. Kang QH, Chen QL, Ren HW, Ru BG. 2001. Growth inhibitory factor (GIF) directly interacts with G protein-Rab3A. Prog Biochem Biophys 28:880-884. (Pubitemid 34343063)
26. Klassen RB, Crenshaw K, Kozyraki R, Verroust PJ, Tio L, Atrian S, Allen PL, Hammond TG. 2004. Megalin mediates renal uptake of heavy metal metallothionein complexes. Am J Physiol Renal Physiol 287:F393-F403. (Pubitemid 39095952)
27. Knipp M, Meloni G, Roschitzki B, Vašák M. 2005. Zn7metallothionein-3 and the synaptic vesicle cycle: interaction of metallothionein-3 with the small GTPase Rab3A. Biochemistry 44:3159-3165. (Pubitemid 40321988)
28. Lahti DW, Hoekman JD, Tokheim AM, Martin BL, Armitage IM. 2005. Identification of mouse brain proteins associated with isoform 3 of metallothionein. Protein Sci 14:1151-1157.
29. Lucas SM, Rothwell NJ, Gibson RM. 2006. The role of inflammation in CNS injury and disease. Br J Pharmacol 147:S232-S240.
30. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD. 1994a. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A 91:584-588.
31. Masters BA, Quaife CJ, Erickson JC, Kelly EJ, Froelick GJ, Zambrowicz BP, Brinster RL, Palmiter RD. 1994b. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci 14:5844-5857.
32. May P, Woldt E, Matz RL, Boucher P. 2007. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med 39:219-228. (Pubitemid 46676481)
33. Molinero A, Penkowa M, Hernández J, Camats J, Giralt M, Lago N, Carrasco J, Campbell IL, Hidalgo J. 2003. Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. J Neuropathol Exp Neurol 62:315-328. (Pubitemid 36330682)
34. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH. 2002. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100:103-117.
35. Nagano S, Satoh M, Sumi H, Fujimura H, Tohyama C, Yanagihara T, Sakoda S. 2001. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur J Neurosci 13:1363-1370. (Pubitemid 32328490)
36. Natale JE, Knight JB, Cheng Y, Rome JE, Gallo V. 2004. Metallothionein I and II mitigate age-dependent secondary brain injury. J Neurosci Res 78:303-314. (Pubitemid 39488255)
37. Nielson KB, Winge DR. 1983. Order of metal binding in metallothionein. J Biol Chem 258:13063-13069.
38. Nielson KB, Winge DR. 1984. Preferential binding of copper to the beta domain of metallothionein. J Biol Chem 259:4941-4946. (Pubitemid 14140590)
39. Olanow C. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444.
40. Ostrakhovitch EA, Olsson PE, Jiang S, Cherian MG. 2006. Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 580:1235-1238. (Pubitemid 43221983)
41. Palmiter RD, Findley SD, Whitmore TE, Durnam DM. 1992. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci U S A 89:6333-6337.
42. Penkowa M, Carrasco J, Giralt M, Moos T, Hidalgo J. 1999a. CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. J Neurosci 19:2535-2545. (Pubitemid 29162402)
43. Penkowa M, Moos T, Carrasco J, Hadberg H, Molinero A, Bluethmann H, Hidalgo J. 1999b. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25:343-357. (Pubitemid 29083834)
44. Penkowa M, Hidalgo J. 2000. Metallothionein I + II expression and their role in experimental autoimmune encephalomyelitis. Glia 32:247-263.
45. Penkowa M, Carrasco J, Giralt M, Molinero A, Hernández J, Campbell IL, Hidalgo J. 2000. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I + II deficient mice. J Cerebral Blood Flow Metab 20:1174-1189. (Pubitemid 30636753)
46. Penkowa M, Hidalgo J. 2001. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-a and apoptotic cell death during experimental autoimmune encephalomyelitis. Exp Neurol 170:1-14. (Pubitemid 32641769)
47. Penkowa M, Espejo C, Martínez-Cáceres EM, Poulsen CB, Montalban X, Hidalgo J. 2001. Altered inflammatory response and increased neurodegeneration in metallothionein I + II deficient mice during experimental autoimmune encephalomyelitis. J Neuroimmunol 119:248-260. (Pubitemid 32918333)
48. Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J, Hidalgo J. 2005. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 79:522-534. (Pubitemid 40283352)
49. Penkowa M, Cáceres M, Borup R, Nielsen FC, Poulsen CB, Quintana A, Molinero A, Carrasco J, Florit S, Giralt M, Hidalgo J. 2006a. Novel roles for Metallothionein-I + II (MT-I + II) in defense responses, neurogenesis and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wildtype and MT-I + II knockout mice. J Neurosci Res 84:1452-1474. (Pubitemid 44683139)
50. Penkowa M, Tió L, Giralt M, Quintana A, Molinero A, Atrian S, Vašák M, Hidalgo J. 2006b. Specificity and divergence in the neurobiological effects of different metallothioneins after brain injury. J Neurosci Res 83:974-984.
51. Pope SN, Lee IR. 2005. Yeast two-hybrid identification of prostatic proteins interacting with human sex hormone-binding globulin. J Steroid Biochem Mol Biol 94:203-208.
52. Poulsen CB, Penkowa M, Borup R, Nielsen FC, Caceres M, Quintana A, Molinero A, Carrasco J, Giralt M, Hidalgo J. 2005. Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis. J Neurochem 92:417-432. (Pubitemid 40194032)
53. Prins ML, Hovda DA. 2003. Developing experimental models to address traumatic brain injury in children. J Neurotrauma 20:123-137. (Pubitemid 36292823)
54. Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL. 2002. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci 22:8790-8796. (Pubitemid 35379048)
55. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD. 1994. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33:7250-7259.
56. Quintana A, Giralt M, Rojas S, Penkowa M, Campbell IL, Hidalgo J, Molinero A. 2005. Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J Neurosci Res 82:701-716. (Pubitemid 41740470)
57. Quintana A, Molinero A, Florit S, Manso Y, Comes G, Carrasco J, Giralt M, Borup R, Nielsen FC, Campbell IL, Penkowa M, Hidalgo J. 2007. Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: from gene to behavior. J Neurosci Res 85:2668-2685. (Pubitemid 47344569)
58. Romero-Isart N, Jensen LT, Zerbe O, Winge DR, Vašák M. 2002. Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform metallothionein-1. J Biol Chem 277:37023-37028.
59. Rothwell NJ, Hopkins SJ. 1995. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurol Sci 18:130-136.
60. Sewell AK, Jensen LT, Erickson JC, Palmiter RD, Winge DR. 1995. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry 34:4740-4747.
61. Takahashi Y, Ogra Y, Suzuki KT. 2005. Nuclear trafficking of metallothionein requires oxidation of a cytosolic partner. J Cell Physiol 202:563-569. (Pubitemid 40041327)
62. Trendelenburg G, Prass K, Priller J, Kapinya K, Polley A, Muselmann C, Ruscher K, Kannbley U, Schmitt AO, Castell S, Wiegand F, Meisel A, Rosenthal A, Dirnagl U. 2002. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J Neurosci 22:5879-5888. (Pubitemid 35387632)
63. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. 1991. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7:337-347.
64. van Lookeren Campagne M, Thibodeaux H, van Bruggen N, Cairns B, Gerlai R, Palmer JT, Williams SP, Lowe DG. 1999. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc Natl Acad Sci U S A 96:12870-12875. (Pubitemid 29513595)
65. Vela JM, Hidalgo J, González B, Castellano B. 1997. Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse. Brain Res 767:345-355. (Pubitemid 27435782)
66. Wolff NA, Abouhamed M, Verroust PJ, Thevenod F. 2006. Megalin-dependent internalization of cadmium-metallothionein and cytotoxicity in cultured renal proximal tubule cells. J Pharmacol Exp Ther 318:782-791. (Pubitemid 44061252)